Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does a Single Oral Dose of Dexamethasone After Successful Emergency Treatment of Migraine Reduce the Incidence or Severity of Rebound Headache Within 48 Hours?

NCT00216736 is registered in ClinicalTrials.gov with The Joseph Epstein Centre for Emergency Medicine Research as lead sponsor.

NCT NCT00216736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00216736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does a Single Oral Dose of Dexamethasone After Successful Emergency Treatment of Migraine Reduce the Incidence or Severity of Rebound Headache Within 48 Hours?
Lead sponsor
The Joseph Epstein Centre for Emergency Medicine Research
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2005
Completion date
July 31, 2007
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine